Compugen Ltd. Reports Q1 2024 Results
Ticker: CGEN · Form: 6-K · Filed: May 20, 2024 · CIK: 1119774
| Field | Detail |
|---|---|
| Company | Compugen Ltd (CGEN) |
| Form Type | 6-K |
| Filed Date | May 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: results, foreign-private-issuer
TL;DR
Compugen dropped Q1 2024 results on 5/20.
AI Summary
Compugen Ltd. reported its first quarter 2024 results on May 20, 2024. The company, headquartered in Holon, Israel, is a biotechnology firm focused on biological products. This report is filed as a Form 6-K, indicating it's a report of a foreign private issuer.
Why It Matters
This filing provides investors with an update on Compugen's financial performance and operational status for the first quarter of 2024.
Risk Assessment
Risk Level: low — This is a routine financial results filing with no new material events or significant financial changes disclosed.
Key Players & Entities
- Compugen Ltd. (company) — Registrant
- May 20, 2024 (date) — Date of press release
- 2024 (date) — Reporting period
- Holon, Israel (location) — Company headquarters
FAQ
What type of report is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is the primary purpose of this filing?
The primary purpose of this filing is to report Compugen Ltd.'s first quarter 2024 results, as detailed in a press release furnished as Exhibit 99.1.
When did Compugen Ltd. issue the press release for its Q1 2024 results?
Compugen Ltd. issued the press release reporting its first quarter 2024 results on May 20, 2024.
Where is Compugen Ltd. located?
Compugen Ltd.'s principal executive offices are located at 26 Harokmim Street, Holon 5885849, Israel.
Does Compugen Ltd. file annual reports under Form 20-F or 40-F?
Compugen Ltd. files annual reports under Form 20-F.
Filing Stats: 225 words · 1 min read · ~1 pages · Grade level 9.4 · Accepted 2024-05-20 07:00:07
Filing Documents
- zk2431483.htm (6-K) — 11KB
- exhibit_99-1.htm (EX-99.1) — 113KB
- image00001.jpg (GRAPHIC) — 416KB
- 0001178913-24-001775.txt ( ) — 697KB
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. COMPUGEN LTD. Date: May 20, 2024 By: /s/ Eran Ben Dor Eran Ben Dor General Counsel